RU2015155596A3 - - Google Patents

Download PDF

Info

Publication number
RU2015155596A3
RU2015155596A3 RU2015155596A RU2015155596A RU2015155596A3 RU 2015155596 A3 RU2015155596 A3 RU 2015155596A3 RU 2015155596 A RU2015155596 A RU 2015155596A RU 2015155596 A RU2015155596 A RU 2015155596A RU 2015155596 A3 RU2015155596 A3 RU 2015155596A3
Authority
RU
Russia
Application number
RU2015155596A
Other languages
Russian (ru)
Other versions
RU2728778C2 (ru
RU2015155596A (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of RU2015155596A publication Critical patent/RU2015155596A/ru
Publication of RU2015155596A3 publication Critical patent/RU2015155596A3/ru
Application granted granted Critical
Publication of RU2728778C2 publication Critical patent/RU2728778C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F226/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen
    • C08F226/02—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen by a single or double bond to nitrogen
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/02—Polyamines
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/02—Polyamines
    • C08G73/024—Polyamines containing oxygen in the form of ether bonds in the main chain
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/40—Concentrating samples
    • G01N1/4077—Concentrating samples by other techniques involving separation of suspended solids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/40—Concentrating samples
    • G01N1/4077—Concentrating samples by other techniques involving separation of suspended solids
    • G01N2001/4083—Concentrating samples by other techniques involving separation of suspended solids sedimentation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/40—Concentrating samples
    • G01N1/4077—Concentrating samples by other techniques involving separation of suspended solids
    • G01N2001/4088—Concentrating samples by other techniques involving separation of suspended solids filtration
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
RU2015155596A 2013-06-05 2014-06-05 Протон-связывающие полимеры для перорального введения RU2728778C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361831445P 2013-06-05 2013-06-05
US61/831,445 2013-06-05
PCT/US2014/041152 WO2014197725A1 (en) 2013-06-05 2014-06-05 Proton-binding polymers for oral administration

Publications (3)

Publication Number Publication Date
RU2015155596A RU2015155596A (ru) 2017-07-18
RU2015155596A3 true RU2015155596A3 (https=) 2018-05-10
RU2728778C2 RU2728778C2 (ru) 2020-07-31

Family

ID=51212941

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2015155596A RU2728778C2 (ru) 2013-06-05 2014-06-05 Протон-связывающие полимеры для перорального введения

Country Status (26)

Country Link
US (8) US9205107B2 (https=)
EP (4) EP3578185B1 (https=)
JP (5) JP6453860B2 (https=)
KR (5) KR102717667B1 (https=)
CN (3) CN105377270B (https=)
AU (3) AU2014274817B2 (https=)
BR (1) BR112015030142B1 (https=)
CA (1) CA2912911C (https=)
CY (3) CY1119611T1 (https=)
DK (3) DK3287133T3 (https=)
ES (3) ES2834485T3 (https=)
HK (1) HK1251151B (https=)
HR (3) HRP20171590T1 (https=)
HU (3) HUE034836T2 (https=)
IL (3) IL242758B (https=)
LT (3) LT3578185T (https=)
MX (3) MX364785B (https=)
NO (1) NO2905572T3 (https=)
PL (2) PL3003327T3 (https=)
PT (3) PT3003327T (https=)
RS (2) RS59033B1 (https=)
RU (1) RU2728778C2 (https=)
SI (3) SI3287133T1 (https=)
SM (2) SMT201900391T1 (https=)
TR (1) TR201909355T4 (https=)
WO (1) WO2014197725A1 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI3287133T1 (sl) * 2013-06-05 2019-09-30 Tricida Inc. Polimeri, ki vežejo protone,za peroralno dajanje
LT3229816T (lt) * 2014-12-10 2020-05-25 Tricida Inc. Protoną prijungiantys polimerai, skirti peroraliniam įvedimui
WO2017193024A1 (en) * 2016-05-06 2017-11-09 Tricida, Inc. Hcl-binding compositions for and method of treating acid-base disorders
BR112019013364A2 (pt) 2016-12-28 2020-04-14 Fujifilm Corp emulsão de polímero contendo átomo de nitrogênio ou sal do mesmo, método de produção para o mesmo e método de produção para partículas
US10934380B1 (en) 2017-09-25 2021-03-02 Tricida, Inc. Crosslinked poly(allylamine) polymer pharmaceutical compositions
CN111225674A (zh) 2017-10-16 2020-06-02 富士胶片株式会社 高磷血症治疗剂
IL319146A (en) 2017-11-03 2025-04-01 Tricida Inc Compositions for and method of treating acid-base disorders
EP3703707A4 (en) * 2017-11-03 2021-08-11 Tricida, Inc. METHOD FOR TREATMENT OF ACID-BASE DISORDER
MA51628A (fr) * 2018-06-04 2021-03-17 Tricida Inc Méthode de traitement de troubles de l'équilibre acido-basique
CN114450364A (zh) * 2019-07-19 2022-05-06 阿卡特肖勒公司 分子上定义明确的抗生物污损和聚离子涂层
US20240254267A1 (en) 2021-03-01 2024-08-01 Renosis, Inc. Crosslinked poly (allylamine) polymer pharmaceutical compositions
SI4053179T1 (sl) 2021-03-01 2026-01-30 Renosis, Inc. Farmacevtski sestavki iz premreženega poli(alilaminskega) polimera
CN118510524A (zh) * 2021-12-14 2024-08-16 上海石趣医药科技有限公司 氧化银和/或其水合物在制备药物中的用途
CN115260355A (zh) * 2022-05-16 2022-11-01 江苏中天药业有限公司 一种阴离子交换树脂、其制备方法、该树脂与药物的复合物和其掩味制剂
KR20240128205A (ko) 2023-02-17 2024-08-26 주식회사 쓰리디코리아 손잡이가 있는 운동기구용 개인별 맞춤형 그립 제조방법 및 그로써 제조된 개인별 맞춤형 그립
KR102902381B1 (ko) 2023-03-21 2025-12-23 지니에듀테크 주식회사 개인별 맞춤형 그립 형상이 형성된 운동기구용 손잡이
CN117164854B (zh) * 2023-07-07 2026-02-27 中国科学院长春应用化学研究所 一种交联型聚酰亚胺及其制备方法

Family Cites Families (125)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6444221B1 (en) 1992-06-30 2002-09-03 Howard K. Shapiro Methods of treating chronic inflammatory diseases using carbonyl trapping agents
US20050090553A1 (en) 1992-06-30 2005-04-28 Shapiro Howard K. Compositions and method for treatment of chronic inflammatory diseases
CA2202397C (en) 1994-10-17 2002-07-16 Peter W. Stacpoole Compositions comprising carbonate/bicarbonate buffered dichloroacetic acid and methods for treatment of metabolic and cardiovascular disorders
US5534259A (en) * 1993-07-08 1996-07-09 Liposome Technology, Inc. Polymer compound and coated particle composition
US5667775A (en) 1993-08-11 1997-09-16 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
US5496545A (en) 1993-08-11 1996-03-05 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
US5648355A (en) 1994-02-09 1997-07-15 Kos Pharmaceutical, Inc. Method of treatment of endogenous, painful gastrointestinal conditions of non-inflammatory, non-ulcerative origin
TW474813B (en) 1994-06-10 2002-02-01 Geltex Pharma Inc Alkylated composition for removing bile salts from a patient
US20020006899A1 (en) 1998-10-06 2002-01-17 Pospisilik Andrew J. Use of dipeptidyl peptidase IV effectors for lowering blood pressure in mammals
US5753706A (en) 1996-12-16 1998-05-19 Hsu; Chen Hsing Methods for treating renal failure
AUPO758297A0 (en) 1997-06-27 1997-07-24 Rowe, James Baber Control of acidic gut syndrome
US6726905B1 (en) 1997-11-05 2004-04-27 Genzyme Corporation Poly (diallylamines)-based phosphate binders
ATE443528T1 (de) * 1998-01-05 2009-10-15 Univ Washington Erhöhter transport unter benutzung membranzerstörender stoffe
AU2682499A (en) 1998-02-17 1999-08-30 Dimitri R. Kioussis Anion binding polymers and the use thereof
US6485703B1 (en) 1998-07-31 2002-11-26 The Texas A&M University System Compositions and methods for analyte detection
US6271264B1 (en) 1998-12-01 2001-08-07 Geltex Pharmaceuticals, Inc. Polymers containing spirobicyclic ammonium moieties as bile acid sequestrants
US6733780B1 (en) 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core
GB9927088D0 (en) 1999-11-17 2000-01-12 Secr Defence Use of poly(diallylamine) polymers
AU2001241077A1 (en) 2000-03-09 2001-09-17 Hisamitsu Pharmaceutical Co. Inc. Crosslinked anion-exchange resin or salt thereof and phosphorus adsorbent comprising the same
AU2001241076A1 (en) 2000-03-09 2001-09-17 Hisamitsu Pharmaceutical Co. Inc. Crosslinked anion-exchange resin or salt thereof
AU2001241095A1 (en) 2000-03-13 2001-09-24 Hisamitsu Pharmaceutical Co. Inc. Preventives and/or remedies for hyperphosphatemia
JP2002028737A (ja) 2000-07-07 2002-01-29 Fujitsu Ltd プレス打ち抜き加工方法及びプレス打ち抜き加工装置
AU2002252632B2 (en) * 2001-04-18 2004-09-23 Genzyme Corporation Low salt forms of polyallylamine
BR0209133A (pt) 2001-04-18 2004-06-15 Genzyme Corp Método para tratar gota e para reduzir os nìveis de ácido úrico n0 sangue
CN1274668C (zh) 2002-03-11 2006-09-13 诺瓦提斯公司 那格列奈的盐
AU2004210013A1 (en) 2003-02-10 2004-08-19 Autogen Research Pty Ltd Therapeutic molecules
TWI335218B (en) 2003-02-19 2011-01-01 Panion & Bf Biotech Inc Ferric organic compounds, uses thereof and methods of making same
CN1540136A (zh) * 2003-10-27 2004-10-27 华东理工大学 一种评价微生物驱油能力的方法
US7459502B2 (en) 2003-11-03 2008-12-02 Ilypsa, Inc. Pharmaceutical compositions comprising crosslinked polyamine polymers
US7767768B2 (en) 2003-11-03 2010-08-03 Ilypsa, Inc. Crosslinked amine polymers
US7385012B2 (en) * 2003-11-03 2008-06-10 Ilypsa, Inc. Polyamine polymers
US7335795B2 (en) 2004-03-22 2008-02-26 Ilypsa, Inc. Crosslinked amine polymers
US7608674B2 (en) * 2003-11-03 2009-10-27 Ilypsa, Inc. Pharmaceutical compositions comprising cross-linked small molecule amine polymers
US7449605B2 (en) 2003-11-03 2008-11-11 Ilypsa, Inc. Crosslinked amine polymers
WO2005065291A2 (en) 2003-12-31 2005-07-21 Genzyme Corporation Enteric coated aliphatic amine polymer bile acid sequestrants
US20080248012A1 (en) 2004-01-29 2008-10-09 Keio University Erythrocyte Function Modifying Substance
US7556799B2 (en) 2004-03-30 2009-07-07 Relypsa, Inc. Ion binding polymers and uses thereof
US7854924B2 (en) 2004-03-30 2010-12-21 Relypsa, Inc. Methods and compositions for treatment of ion imbalances
BRPI0509331B8 (pt) 2004-03-30 2021-05-25 Ilypsa Inc uso de uma composição de ligação de sódio
US7429394B2 (en) 2004-03-30 2008-09-30 Relypsa, Inc. Ion binding compositions
US8282960B2 (en) 2004-03-30 2012-10-09 Relypsa, Inc. Ion binding compositions
US8192758B2 (en) 2004-03-30 2012-06-05 Relypsa, Inc. Ion binding compositions
US8399025B2 (en) 2004-06-04 2013-03-19 Board Of Regents, The University Of Texas System Polyamine modified particles
JP2008506771A (ja) 2004-07-19 2008-03-06 エヌ．ブイ．・ヌートリシア 血糖値を調節するためのアスパルテートを使用するための調製物
DE102004035808A1 (de) 2004-07-21 2006-03-16 Kasch, Helmut, Dr. Ammoniumsalze und Ammoniumsalz-Mineralsalzchlatrate als Transport- und Wirkform für pharmazeutische-medizinische und als Phasentransfermittel für chemische Anwendungen
US8569277B2 (en) 2004-08-11 2013-10-29 Palo Alto Investors Methods of treating a subject for a condition
US20070293429A1 (en) 2004-10-08 2007-12-20 Therapei Pharmaceuticals, Inc. Vasoactive Intestinal Polypeptide Compositions
US20080214440A1 (en) 2004-10-08 2008-09-04 Forbes Medi-Tech (Research), Inc. Vasoactive intestinal polypeptide compositions
CA2583634C (en) * 2004-10-13 2013-03-19 Ilypsa, Inc. Crosslinked amine polymers
US7985418B2 (en) 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
ITME20040015A1 (it) 2004-12-07 2005-03-07 Vincenzo Savica Chewing gum, caramelle gommose, pastiglie, compresse a lento rilascio di chelanti fosfato e/o fosforo salivare e capsule a lento rilascio di chelanti fosfato e/o fosforo a livello gastroenterico.
WO2006078629A2 (en) * 2005-01-18 2006-07-27 Duke University In-situ crosslinkable elastin-like polypeptides for defect filling in cartilaginous tissue repair
CA2613875C (en) 2005-07-04 2018-09-25 Ramu Krishnan Improved drug or pharmaceutical compounds and a preparation thereof
NZ566743A (en) 2005-08-18 2010-07-30 Globoasia Llc Pharmaceutical-grade ferric organic compounds, uses thereof and methods of making same
US8986669B2 (en) 2005-09-02 2015-03-24 Genzyme Corporation Method for removing phosphate and polymer used therefore
CA2624112A1 (en) * 2005-09-30 2007-04-05 Ilypsa, Inc. Methods for preparing core-shell composites having cross-linked shells and core-shell composites resulting therefrom
GB2446077B (en) * 2005-09-30 2010-10-13 Ilypsa Inc Methods and compositions for selectively removing potassium ion from the gastrointestinal tract of a mammal
WO2007038801A2 (en) 2005-09-30 2007-04-05 Ilypsa, Inc. Monovalent cation-binding compositions comprising core-shell particles having crosslinked poly-vinylic shells, and methods of use thereof
EP1945196A2 (en) 2005-11-08 2008-07-23 Genzyme Corporation Magnesium-containing polymers for hyperphosphatemia
CN101355953B (zh) 2005-11-08 2014-07-09 味之素株式会社 麻醉苏醒促进剂
ITMI20052461A1 (it) 2005-12-22 2007-06-23 Univ Degli Studi Milano Sistemi microparticellari per la somministrazione orale di sostanze biologicamente attive
RU2008136081A (ru) 2006-02-14 2010-03-20 Тева Фармасьютикл Индастриес Лтд. (Il) Фармацевтические составы с алифатическими аминными полимерами и способы их производства
EP2016114A2 (en) 2006-05-05 2009-01-21 Genzyme Corporation Amine condensation polymers as phosphate sequestrants
WO2008005217A2 (en) 2006-07-05 2008-01-10 Genzyme Corporation Iron(ii)-containing treatments for hyperphosphatemia
CN101541235A (zh) * 2006-07-18 2009-09-23 基酶有限公司 胺类树状物
AU2007275711A1 (en) 2006-07-18 2008-01-24 Genzyme Corporation Amine dendrimers
US8391873B2 (en) 2006-07-21 2013-03-05 Qualcomm Incorporated Systems and methods for coordinating supplementary services for voice telephone calls in a centralized fashion
WO2008016729A1 (en) 2006-08-04 2008-02-07 Nastech Pharmaceutical Company Inc. Compositions for intranasal delivery of human insulin and uses thereof
US7964182B2 (en) * 2006-09-01 2011-06-21 USV, Ltd Pharmaceutical compositions comprising phosphate-binding polymer
BRPI0716066A2 (pt) 2006-09-01 2013-09-17 Genzyme Corp composiÇço farmacÊutica, mÉtodo para tratar doenÇas, polÍmero de amina, rede polimÉrica, mÉtodo para preparar um polÍmero de amina, e, composto de amina
CA2749074A1 (en) 2006-09-01 2008-05-29 Usv Limited Process for the preparation of sevelamer hydrochloride and formulation thereof
JP5427029B2 (ja) 2006-09-06 2014-02-26 スキャンポ・アーゲー 消化管の重炭酸分泌を促進するための方法および組成物
EP2066293A2 (en) 2006-09-29 2009-06-10 Genzyme Corporation Amide dendrimer compositions
US8163799B2 (en) 2006-12-14 2012-04-24 Genzyme Corporation Amido-amine polymer compositions
JP2010519298A (ja) 2007-02-23 2010-06-03 ゲンズイメ コーポレーション アミンポリマー組成物
US20080207766A1 (en) 2007-02-27 2008-08-28 Agi Therapeutics Research Ltd. Methods and compositions for treating at least one upper gastrointestinal symptom
EP2131820A1 (en) 2007-03-08 2009-12-16 Genzyme Corporation Sulfone polymer compositions
TWI445540B (zh) 2007-04-20 2014-07-21 Ajinomoto Kk 抗低體溫組成物
EP2152277A1 (en) 2007-04-27 2010-02-17 Genzyme Corporation Amido-amine dendrimer compositions
WO2009005838A2 (en) 2007-07-02 2009-01-08 Cognate3 Llc Process for the preparation of a non-corrosive base solution and methods of using same
BRPI0813928A2 (pt) * 2007-07-11 2014-12-30 Toray Industries Polialilamina reticulada, composição farmacêutica, agente terapêutico ou profilático para hiperfosfatemia, método terapêutico ou profilático para hiperfosfatemia, uso da polialilamina reticulada, e, composto para terapia ou profilaxia de hiperfosfatemia
EP2016947A1 (en) 2007-07-17 2009-01-21 Chemo Ibérica, S.A. Novel one step process for preparing cross-linked poly(allylamine) polymers
WO2009023544A2 (en) 2007-08-10 2009-02-19 Ilypsa, Inc. Dosage unit anion-exchange polymer pharmaceutical compositions
US20090181359A1 (en) * 2007-10-25 2009-07-16 Lou Sheng C Method of performing ultra-sensitive immunoassays
US20090156647A1 (en) 2007-12-12 2009-06-18 Iovate T. & P. Inc. Method for maintaining physiological pH levels during intensive physical exercise
PA8807201A1 (es) 2007-12-14 2009-07-23 Genzyme Corp Composiciones farmaceuticas
WO2009078958A1 (en) 2007-12-14 2009-06-25 Genzyme Corporation Coated pharmaceutical compositions
WO2009097127A1 (en) 2008-01-31 2009-08-06 Genzyme Corporation Pharmaceutical compositions
WO2009114650A1 (en) 2008-03-11 2009-09-17 Chakshu Research, Inc. Methods and compositions for treating inflammation and inflammation-related pathologies
WO2009125433A2 (en) 2008-04-08 2009-10-15 Usv Limited Process for preparation of amine polymer salt
ATE540660T1 (de) 2008-04-11 2012-01-15 Gp Investimenti S R L Handstück für ultraschallbehandlungen von menschlichem gewebe
US20110142952A1 (en) 2008-06-20 2011-06-16 Harris David J Pharmaceutical Compositions
DE102008030046A1 (de) 2008-06-25 2009-12-31 Ratiopharm Gmbh Kompaktiertes Polyallylamin-Polymer
US20100008988A1 (en) 2008-07-14 2010-01-14 Glenmark Generics, Ltd. Tablet compositions of amine polymers
UY32030A (es) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
US8337824B2 (en) 2008-08-22 2012-12-25 Relypsa, Inc. Linear polyol stabilized polyfluoroacrylate compositions
US20100104527A1 (en) 2008-08-22 2010-04-29 Relypsa, Inc. Treating hyperkalemia with crosslinked cation exchange polymers of improved physical properties
BRPI0920515B1 (pt) 2008-09-25 2018-03-20 Vive Nano, Inc. Composição compreendendo nanopartícula de polímero e composto ativo agrícola
US20110268666A1 (en) 2008-09-29 2011-11-03 Yissum Research Development Company of the Research University of Jerusalem, Ltd. Novel gastroretentive delivery system
WO2010059384A1 (en) 2008-10-30 2010-05-27 Janssen Pharmaceutica Nv Process for the preparation of tri-substituted pyridine and tri-substituted pyrimidine derivatives useful as gdir agonists
US20100166861A1 (en) 2008-12-29 2010-07-01 Kelly Noel Lynch Pharmaceutical formulations of sevalamer, or salts thereof, and copovidone
US20110081413A1 (en) 2009-01-22 2011-04-07 Ashok Omray Pharmaceutical Compositions Comprising Phosphate-Binding Polymer
CN102917699A (zh) 2009-10-13 2013-02-06 密执安大学评议会 树枝状聚合物组合物和合成方法
ES2720869T3 (es) 2009-10-22 2019-07-25 Synthon Bv Composiciones farmacéuticas de sevelámero
JP5984675B2 (ja) 2009-12-07 2016-09-06 アイアンウッド ファーマシューティカルズ インコーポレイテッド 胃腸障害の療法
DE112011100657T5 (de) 2010-02-24 2013-02-28 Relypsa, Inc. Amin-polymere zur verwendung als gallensäuresequestriermittel
WO2011106542A2 (en) * 2010-02-24 2011-09-01 Relypsa, Inc. Crosslinked polyvrnylamine, poly all ylamine, and polyethyleneimine for use as bile acid sequestrants
BR112012021448A2 (pt) 2010-02-24 2016-05-31 Relypsa Inc polímero de amina, método para tratar doença, método de remoção de sais biliares de um indivíduo animal, método para melhorar o controle glicêmico em um indivíduo, e, processo para preparar o polímero de amina.
RU2417782C1 (ru) * 2010-03-03 2011-05-10 Федеральное государственное образовательное учреждение высшего профессионального образования "Белгородская государственная сельскохозяйственная академия" Способ лечения ацидоза рубца
IT1406068B1 (it) 2010-07-22 2014-02-06 Medestea Int Spa Polidesossiribonucleotidi (pdrn) per l'impiego nel trattamento di condizioni di acidosi e composizioni a base di polidesossiribonucleotidi per il suddetto impiego
SG187787A1 (en) * 2010-08-10 2013-03-28 Amgen Inc Dual function in vitro target binding assay for the detection of neutralizing antibodies against target antibodies
US20130156720A1 (en) 2010-08-27 2013-06-20 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
KR101238210B1 (ko) 2011-06-30 2013-03-04 엘지전자 주식회사 이동 단말기
US20130137772A1 (en) 2011-11-29 2013-05-30 Raymond J. Bergeron Hydroxypolyamine salts
SG11201408521WA (en) 2012-06-21 2015-01-29 Keryx Biopharmaceuticals Inc Use of ferric citrate in the treatment of chronic kidney disease patients
JP6475624B2 (ja) 2012-10-08 2019-02-27 レリプサ， インコーポレイテッド 高血圧症及び高カリウム血症を治療するためのカリウム結合剤
SI3287133T1 (sl) 2013-06-05 2019-09-30 Tricida Inc. Polimeri, ki vežejo protone,za peroralno dajanje
HK1223031A1 (zh) 2013-11-04 2017-07-21 凯克斯生物制药公司 用於降低慢性肾病患者的心力衰竭的枸橼酸铁
LT3229816T (lt) 2014-12-10 2020-05-25 Tricida Inc. Protoną prijungiantys polimerai, skirti peroraliniam įvedimui
WO2017193024A1 (en) 2016-05-06 2017-11-09 Tricida, Inc. Hcl-binding compositions for and method of treating acid-base disorders
IL319146A (en) 2017-11-03 2025-04-01 Tricida Inc Compositions for and method of treating acid-base disorders
EP3703707A4 (en) 2017-11-03 2021-08-11 Tricida, Inc. METHOD FOR TREATMENT OF ACID-BASE DISORDER
WO2019236124A1 (en) 2018-06-04 2019-12-12 Tricida, Inc. Method of treating acid-base disorders
MA51628A (fr) 2018-06-04 2021-03-17 Tricida Inc Méthode de traitement de troubles de l'équilibre acido-basique
WO2019236639A1 (en) 2018-06-04 2019-12-12 Tricida, Inc. Method of treating acid-base disorders

Also Published As

Publication number Publication date
CN105377270B (zh) 2020-09-04
KR20210131457A (ko) 2021-11-02
AU2019275584A1 (en) 2020-01-02
DK3578185T3 (da) 2020-11-02
EP3003327B1 (en) 2017-08-09
AU2014274817B2 (en) 2019-05-23
HRP20171590T1 (hr) 2017-12-29
ES2733493T3 (es) 2019-11-29
KR102318910B1 (ko) 2021-10-29
HUE051198T2 (hu) 2021-03-01
LT3578185T (lt) 2020-11-25
EP3578185A1 (en) 2019-12-11
CN111671767A (zh) 2020-09-18
US11197887B2 (en) 2021-12-14
HUE034836T2 (en) 2018-03-28
KR102717667B1 (ko) 2024-10-16
LT3003327T (lt) 2017-12-27
CY1121801T1 (el) 2020-07-31
EP3812761B1 (en) 2025-12-24
ES2834485T3 (es) 2021-06-17
PT3578185T (pt) 2020-11-10
IL271932A (en) 2020-02-27
NO2905572T3 (https=) 2017-12-16
AU2019219800B1 (en) 2019-09-19
KR102633597B1 (ko) 2024-02-06
JP2016520652A (ja) 2016-07-14
MX364785B (es) 2019-05-07
EP3287133A1 (en) 2018-02-28
SI3578185T1 (sl) 2021-01-29
DK3287133T3 (da) 2019-07-01
KR20230114326A (ko) 2023-08-01
CN105377270A (zh) 2016-03-02
CA2912911A1 (en) 2014-12-11
PT3003327T (pt) 2017-11-09
US9205107B2 (en) 2015-12-08
JP6759316B2 (ja) 2020-09-23
MX2015016527A (es) 2016-07-22
JP2022107004A (ja) 2022-07-20
US20220096534A1 (en) 2022-03-31
KR102941408B1 (ko) 2026-03-20
US20180280428A1 (en) 2018-10-04
US20190134075A1 (en) 2019-05-09
JP7075455B2 (ja) 2022-05-25
CN111671767B (zh) 2024-03-08
IL271932B (en) 2020-11-30
WO2014197725A1 (en) 2014-12-11
SMT202000596T1 (it) 2021-01-05
RU2728778C2 (ru) 2020-07-31
JP2020203917A (ja) 2020-12-24
EP3003327A1 (en) 2016-04-13
EP3578185B1 (en) 2020-08-05
US9925214B2 (en) 2018-03-27
HUE043999T2 (hu) 2019-09-30
US20160074430A1 (en) 2016-03-17
CY1123673T1 (el) 2022-03-24
KR20240023672A (ko) 2024-02-22
HK1222120A1 (zh) 2017-06-23
AU2014274817A1 (en) 2015-12-24
CN111671766A (zh) 2020-09-18
JP7588871B2 (ja) 2024-11-25
HRP20191074T1 (hr) 2019-09-20
DK3003327T3 (en) 2017-10-23
BR112015030142B1 (pt) 2023-03-07
US20150056451A1 (en) 2015-02-26
US10391118B2 (en) 2019-08-27
US10363268B2 (en) 2019-07-30
AU2019275584B2 (en) 2021-10-21
PL3287133T3 (pl) 2019-10-31
US20190231812A1 (en) 2019-08-01
HK1251151B (en) 2020-04-24
SI3287133T1 (sl) 2019-09-30
MX2021013880A (es) 2022-06-02
PT3287133T (pt) 2019-07-12
KR20240152425A (ko) 2024-10-21
IL242758B (en) 2020-01-30
RU2015155596A (ru) 2017-07-18
BR112015030142A2 (pt) 2017-07-25
SI3003327T1 (en) 2018-01-31
KR20160041855A (ko) 2016-04-18
SMT201900391T1 (it) 2019-09-09
HRP20201767T1 (hr) 2020-12-25
RS59033B1 (sr) 2019-08-30
JP2019065024A (ja) 2019-04-25
IL278183B (en) 2021-09-30
EP3287133B1 (en) 2019-04-17
JP2025024009A (ja) 2025-02-19
LT3287133T (lt) 2019-07-10
HK1223288A1 (en) 2017-07-28
CA2912911C (en) 2023-10-03
ES2646271T3 (es) 2017-12-13
MX2019005300A (es) 2019-08-12
US20200206260A1 (en) 2020-07-02
TR201909355T4 (tr) 2019-07-22
US20180015121A1 (en) 2018-01-18
MX387845B (es) 2025-03-19
PL3003327T3 (pl) 2018-02-28
JP6453860B2 (ja) 2019-01-16
US10369169B1 (en) 2019-08-06
IL278183A (en) 2020-11-30
CY1119611T1 (el) 2018-04-04
RS61005B1 (sr) 2020-11-30
US9993500B2 (en) 2018-06-12
EP3812761A1 (en) 2021-04-28
CN111671766B (zh) 2024-03-08

Similar Documents

Publication Publication Date Title
BR112015007533A2 (https=)
BR112016005415A2 (https=)
BR102016010778A2 (https=)
BR112014018502A2 (https=)
BR112014019326A2 (https=)
BR112014018516A2 (https=)
BR112014018480A2 (https=)
BR112014017855A2 (https=)
BR112014020341A2 (https=)
BR112014017669A2 (https=)
BR112014021878A2 (https=)
RU2015155596A3 (https=)
BR112014018468A2 (https=)
BR112014019204A2 (https=)
BR112014017901A2 (https=)
BR112014018207A2 (https=)
BR112015015948A2 (https=)
BR112014017722A2 (https=)
BR112014017794A2 (https=)
BR112014017653A2 (https=)
BR112016000006A2 (https=)
BR112014018578A2 (https=)
BR112014018483A2 (https=)
BR112014017601A2 (https=)
BR112015015312A2 (https=)

Legal Events

Date Code Title Description
HE9A Changing address for correspondence with an applicant